Opportunity
DIBBS #SPE2DP-26-T-2535
DLA Solicitation for Ceftriaxone Injection, USP, 1 Gram – Fort Bragg Delivery
Posted
March 31, 2026
Respond By
April 06, 2026
Identifier
SPE2DP-26-T-2535
NAICS
325412
This procurement seeks Ceftriaxone Injection, USP, for military medical supply needs: - Government Buyer: - Defense Logistics Agency (DLA), DLA Troop Support Medical Supply Chain Pharm FSA, Philadelphia, PA - OEMs (Original Equipment Manufacturers): - HIKMA PHARMACEUTICALS USA INC. - SAGENT PHARMACEUTICALS, INC - WG CRITICAL CARE, LLC - Vendors/Manufacturers: - HIKMA PHARMACEUTICALS USA INC. (NDC00143-9857-25) - SAGENT PHARMACEUTICALS, INC (NDC25021-0106-10) - WG CRITICAL CARE, LLC (NDC44567-0701-25) - Products Requested: - Ceftriaxone Injection, USP, 1 gram strength, sterile, for intravenous or intramuscular use - Packaged as 25 single-use vials per package - National Stock Number (NSN): 6505-01-554-4282 - Total quantity: 14 packages (10, 3, and 1 across three line items) - Unique/Notable Requirements: - Only approved OEMs/part numbers accepted - Strict packaging and labeling standards - Shelf life: 24 months required, with minimum 21 months remaining at delivery - Delivery required within 5 days of order - Delivery location: Fort Bragg, NC (3D SFG SSA AWCF SSF) - No additional technical attachments or service line items specified
Description
CEFTRIAXONE INJECTI (QTY: 10, NSN: 6505-01-554-4282, Purchase Request: 7016140998) Approved Sources: - CAGE: 32655, Part No: NDC00143-9857-25, Company: HIKMA PHARMACEUTICALS USA INC. - CAGE: 4RP13, Part No: NDC25021-0106-10, Company: SAGENT PHARMACEUTICALS, INC - CAGE: 6XJQ8, Part No: NDC44567-0701-25, Company: WG CRITICAL CARE, LLC
CEFTRIAXONE INJECTI (QTY: 3, NSN: 6505-01-554-4282, Purchase Request: 7016122995) Approved Sources: - CAGE: 32655, Part No: NDC00143-9857-25, Company: HIKMA PHARMACEUTICALS USA INC. - CAGE: 4RP13, Part No: NDC25021-0106-10, Company: SAGENT PHARMACEUTICALS, INC - CAGE: 6XJQ8, Part No: NDC44567-0701-25, Company: WG CRITICAL CARE, LLC
CEFTRIAXONE INJECTI (QTY: 1, NSN: 6505-01-554-4282, Purchase Request: 7016144906) Approved Sources: - CAGE: 32655, Part No: NDC00143-9857-25, Company: HIKMA PHARMACEUTICALS USA INC. - CAGE: 4RP13, Part No: NDC25021-0106-10, Company: SAGENT PHARMACEUTICALS, INC - CAGE: 6XJQ8, Part No: NDC44567-0701-25, Company: WG CRITICAL CARE, LLC